Skip to main content
logo
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
4.960
+0.060 (1.22%)
Sep 28, 2026, 2:27 PM EDT - Market open

Champions Oncology Financials Overview

Millions USD. Fiscal year is May - Apr.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Revenue
60.6659.4356.9450.1653.8749.11
Revenue Growth
6.65%4.36%13.54%-6.90%9.70%19.66%
Gross Profit
30.2228.5328.5620.7524.3425.48
Operating Income
-0.93-1.034.85-6.92-4.450.61
Net Income
-1.14-1.184.7-7.28-5.340.55
Earnings Per Share
-0.08-0.080.33-0.54-0.390.04
EPS Growth
-----100.01%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Cash & Investments
4.364.879.792.6210.129.01
Total Debt
10.974.66.337.438.69.47
Net Cash (Debt)
-6.610.273.46-4.811.52-0.46
Net Cash Growth
--92.08%----
Net Cash Per Share
-0.480.020.24-0.360.11-0.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Operating Cash Flow
-5.56-4.477.39-6.143.976.5
Capital Expenditures
-0.57-0.56-0.39-0.84-2.87-2.38
Free Cash Flow
-6.14-5.047-6.971.14.11
Free Cash Flow Growth
-----73.26%-

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Gross Margin
49.82%48.00%50.15%41.38%45.18%51.88%
Operating Margin
-1.54%-1.73%8.51%-13.80%-8.26%1.24%
Pretax Margin
-1.47%-1.56%8.12%-14.57%-9.78%1.19%
Profit Margin
-1.87%-1.98%8.25%-14.51%-9.90%1.12%
FCF Margin
-10.12%-8.48%12.29%-13.90%2.04%8.38%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
PE Ratio
--20.85--189.51
Forward PE
-114.60119.1764.1043.8142.95
P/FCF Ratio
--14.01-60.6425.25
PS Ratio
1.121.391.721.321.242.12